Examination of the Pancreas in New-onset Diabetes
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 1000
Summary
- Conditions
- Diabetes Mellitus
- Type
- Observational
- Design
- Observational Model: Cohort
- Time Perspective: Prospective
Participation Requirements
- Age
- Between 50 years and 85 years
- Gender
- Both males and females
Description
Compared to the general population, subjects >50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed...
Compared to the general population, subjects >50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed diabetes will be prospectively identified. Those with weight loss and/or elevated pancreatic cancer marker (CA 19-9) will undergo pancreatic imaging. All subjects will be followed up to 24 months. If successful in identifying surgically removable PaC, this study will fundamentally change our practice and will be a major breakthrough in PaC treatment and research.
Tracking Information
- NCT #
- NCT02001337
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Gloria Petersen, PhD Mayo Clinic
- Gloria Petersen, PhD Mayo Clinic